🇺🇸 FDA
Patent

US 6172070

Substituted O6-benzyl-8-aza-guanines and 6(4)-benzyloxypyrimidines

expired A61PA61P35/00A61P43/00

Quick answer

US patent 6172070 (Substituted O6-benzyl-8-aza-guanines and 6(4)-benzyloxypyrimidines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P35/00, A61P43/00